WO2011093664A3 - （１ｓ,２ｓ,３ｓ,４ｓ）-５- 아미노사이클로펜탄 - １,２,３,４- 테트라올을 포함하는 항비만 조성물. - Google Patents

（１ｓ,２ｓ,３ｓ,４ｓ）-５- 아미노사이클로펜탄 - １,２,３,４- 테트라올을 포함하는 항비만 조성물. Download PDF

Info

Publication number
WO2011093664A3
WO2011093664A3 PCT/KR2011/000591 KR2011000591W WO2011093664A3 WO 2011093664 A3 WO2011093664 A3 WO 2011093664A3 KR 2011000591 W KR2011000591 W KR 2011000591W WO 2011093664 A3 WO2011093664 A3 WO 2011093664A3
Authority
WO
WIPO (PCT)
Prior art keywords
aminocyclopentane
tetraol
composition containing
obesity
obesity composition
Prior art date
Application number
PCT/KR2011/000591
Other languages
English (en)
French (fr)
Other versions
WO2011093664A2 (ko
Inventor
정영훈
지옥표
오좌섭
안은경
이정아
김인수
이경일
Original Assignee
성균관대학교 산학협력단
재단법인 경기과학기술진흥원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성균관대학교 산학협력단, 재단법인 경기과학기술진흥원 filed Critical 성균관대학교 산학협력단
Publication of WO2011093664A2 publication Critical patent/WO2011093664A2/ko
Publication of WO2011093664A3 publication Critical patent/WO2011093664A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 (1S,2S,3S,4S)-5-아미노사이클로펜탄-1,2,3,4-테트라올을 포함하는 항비만 조성물에 관한 것으로, (1S,2S,3S,4S)-5-아미노사이클로펜탄-1,2,3,4-테트라올이 지방전구세포에서 전구세포로의 분화를 억제하므로, 비만 또는 비만과 관련된 다양한 질환의 예방 또는 치료에 유용하게 사용될 수 있다.
PCT/KR2011/000591 2010-01-27 2011-01-27 （１ｓ,２ｓ,３ｓ,４ｓ）-５- 아미노사이클로펜탄 - １,２,３,４- 테트라올을 포함하는 항비만 조성물. WO2011093664A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100007547A KR101074954B1 (ko) 2010-01-27 2010-01-27 （１ｓ,２ｓ,３ｓ,４ｓ）―５―아미노사이클로펜탄―１,２,３,４―테트라올을 포함하는 항비만 조성물
KR10-2010-0007547 2010-01-27

Publications (2)

Publication Number Publication Date
WO2011093664A2 WO2011093664A2 (ko) 2011-08-04
WO2011093664A3 true WO2011093664A3 (ko) 2012-01-05

Family

ID=44319997

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/000591 WO2011093664A2 (ko) 2010-01-27 2011-01-27 （１ｓ,２ｓ,３ｓ,４ｓ）-５- 아미노사이클로펜탄 - １,２,３,４- 테트라올을 포함하는 항비만 조성물.

Country Status (2)

Country Link
KR (1) KR101074954B1 (ko)
WO (1) WO2011093664A2 (ko)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684026A (en) * 1994-11-22 1997-11-04 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Aminocyclopentane derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684026A (en) * 1994-11-22 1997-11-04 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Aminocyclopentane derivative

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ADAM DREWNOWSKI ET AL.: "Effects of inhibitors of carbohydrate absorption or lipid metabolism on meal patterns of Zucker rats", PHARMACOLOGY BIO-CHEMISTRY & BEHAVIOR, vol. 23, 1985, pages 811 - 821 *
LUCAS GARTENMANN DICKSON ET AL.: "Structure-activity relationships in amino- cyclopentitol glycosidase inhibitors", ORG. BIOMOL. CHEM., vol. 2, 2004, pages 1217 - 1226 *

Also Published As

Publication number Publication date
KR101074954B1 (ko) 2011-10-18
KR20110087899A (ko) 2011-08-03
WO2011093664A2 (ko) 2011-08-04

Similar Documents

Publication Publication Date Title
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2011057282A3 (en) Tissue closure devices, device and systems for delivery, kits and methods therefor
WO2010118312A3 (en) Tissue closure devices, device and systems for delivery, kits and methods therefor
WO2011140202A3 (en) Mif modulators
WO2011130302A3 (en) Method of treating obesity using antioxidant inflammation modulators
SG10201907588XA (en) Androgen Receptor Modulators And Uses Thereof
IL225198A (en) Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes
MX343135B (es) Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
IN2012DN03883A (ko)
MY161495A (en) Virus like particle compositions and methods of use
IN2012DN00971A (ko)
MX349886B (es) Moleculas de union anti-pseudomonas lectina pisum satinum (psl) y usos de las mismas.
EP2488023A4 (en) ANTIMICROBIAL COMPOSITION
IN2012DN01434A (ko)
WO2012003501A3 (en) Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
EA201490688A1 (ru) 2-тиопиримидиноны
MX349948B (es) Proteínas inmunógenas y composiciones para el tratamiento y prevención de streptococcus agalactiae.
WO2009114461A3 (en) Angiotensin (1-7) dosage forms and uses thereof
EP2438923A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF OBESITY-RELATED DISORDERS MEDIATED BY AMPK ACTIVATION AND THE ACTIVE INGREDIENTS OF WHICH HAVE 2,5-BIS-ARYL-3,4-DIMETHYLTETRAHYDROFURAN LIGNANS
WO2011098778A3 (en) Peptides for vaccines against birch allergy
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
MX361233B (es) Inhibidores de hsp90 c-terminales.
WO2011147034A8 (en) Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereof
WO2012048115A3 (en) Polypeptides and their use in treating and limiting respiratory syncytial virus infection
WO2013192238A3 (en) Compositions and methods for treatment of diabetes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11737303

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11737303

Country of ref document: EP

Kind code of ref document: A2